Skip to main content
Log in

Absorbable antibacterial envelope cost effective to prevent CIED infection in Europe

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. The study was affiliated with, and funded by, Medtronic.

  2. Worldwide Randomized Antibiotic Envelope Infection Prevention Trial

Reference

  • Boriani G, et al. Cost-Effectiveness Analyses of an Absorbable Antibacterial Envelope for Use in Patients at Increased Risk of Cardiac Implantable Electronic Device Infection in Germany, Italy, and England. Value in Health 24: 930-938, No. 7, Jul 2021. Available from: URL: http://doi.org/10.1016/j.jval.2020.12.021

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Absorbable antibacterial envelope cost effective to prevent CIED infection in Europe. PharmacoEcon Outcomes News 884, 1 (2021). https://doi.org/10.1007/s40274-021-7908-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7908-4

Navigation